Media & events
news
Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics
July 9, 2019
Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics Gilead will have exclusive rights to Lyndra’s...
Read More
publications
200px-Elsevier.svg
A pharmaceutical answer to non-adherence: Once weekly oral memantine for Alzheimer’s disease
Rosemary Kanasty, Susan Low, Nupura Bhise, JungYanga, ErickPeeke, MarleneSchwarz, JimWright, BennettCarter, SaumyaMoorthy, TylerGrant, BenDeBenedictis, MeganBishoff, CraigSimses, Andrew M.Bellinger
| URL : | View Project |
|---|
events
Lyndra Presents @ BIO International
Join us on Thursday, June 5th, at 5pm when Andrew Bellinger, our CSO, presents our 2019 Company Update at BIO International, Philadelphia Convention Center, Theater 4
awards
2019 Xconomy Awards Finalist in Startup Category
We are honored to be named a finalist for the Xconomy Awards in the #startup category for our work making daily pills a thing of the past.
